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Abstract - The object recognition paradigm is widely used to determine cognitive status in 
animal models of Alzheimer’s disease because it probes one of its major symptoms. The 
severity and the nature of recognition deficits expand as Alzheimer’s pathology spreads 
through medial temporal lobe networks and tightly connected brain structures. We first 
reviewed characteristics and neuroanatomical bases of usual variants of the object 
recognition paradigm in humans and animals. The pertinence of behavioral data provided by 
the object recognition paradigm was then analyzed in regard to the neuropathological 
phenotype of animal models obtained through transgenic approaches and stereotaxic Aβ 
injection, or in species naturally expressing age-dependent amyloid and tau pathologies. We 
further outlined clear advantages and possible limits in the translational value of the object 
recognition paradigm. Future progress could rely on better understanding of networks 
supporting recognition memory in each paradigm variant and the parallel development of 







When you think of Alzheimer’s disease (AD), you immediately think of the dramatic 
deficit in recognition memory associated to this neurodegenerative disease. Alzheimer's 
patients are well known to forget about familiar people, place or object. What leads to 
frustrations and interference with daily tasks in the earlier stages of the disease will get 
worse and end up being a deeply disabling condition to the patient and a heartbreaking 
experience for caregivers and family. As a matter of fact, tests designed to probe recognition 
memory were naturally included in the battery of neuropsychological tests developed for 
diagnosis and monitoring of AD patients. Thus it is not surprising that the recognition tasks 
designed for animals were also widely used in batteries of task designed to phenotype 
prototypic models of AD (see the PDAPP mice as a typical example, Dodart et al. 1999; 
Chen et al. 2000). It was then naturally included in preclinical evaluations of new therapeutic 
approaches in these models (Grayson et al. 2015). Another factor that made these tasks 
inescapable in regard to AD research is that case studies and imagery approaches in 
humans all agreed on the fact that brain structures involved in recognition memory were also 
those affected early in the disease, especially within the medial temporal lobe (including the 
famous hippocampus). 
The present chapter will begin with a survey of what is known about the relations 
between deficits in object-based recognition tasks and neuropathology in AD patients, as 
well as the variety of experimental devices used to assess this function in humans. Then we 
will describe how these recognition tasks were transposed in animals with a focus on the 
most widely used object recognition (OR) and object location (OL) tasks and a non 
exhaustive description of corresponding experimental setups and protocols based on object 
exploration. Although the issue is complex and definitely needs further investigations, we will 
evoke current knowledge on neuroanatomical basis of OR memory whenever pertinent to AD 
models. Therefore much emphasis will be given to the medial temporal lobe, which can be 
simplistically described as a crossroad region with to parallel streams processing object-
based information (perirhinal cortex and lateral entorhinal cortex stream) and spatial-based 
(parahippocampal/postrhinal cortex and medial entorhinal cortex stream) information 
converging to the hippocampus appointed in charge of integrating spatial/context and object 
information as a whole (Figure 1; Knierim et al. 2014). Thereafter, a selection of 
representative animal models of AD will be analyzed to evaluate to what extent the 
emergence of recognition deficits can be related to the progression of AD-like pathology. 
This discussion will show both the valuable contribution and the limits of the object 
recognition paradigm in the context of AD research. As the future is heavy with hope in better 
understanding and treating AD, a few suggestions will be given on the most promising ways 
to take advantage of the object exploration paradigm with the parallel development of new 
AD models. So first, we will begin with an overview of OR memory in AD, which seemed a 
mandatory step before tackling the same function in animal models of AD. 
 
2. Neuropathology and object recognition memory in  Alzheimer’s disease 
AD is characterized by a gradual cognitive decline, which begins with anterograde 
amnesia. As the disease progresses, progressive visuospatial deficits, executive dysfunction, 
or aphasia syndromes emerge, as well as perturbations in sleep/wake cycles, agitation and 
changes in personality. The vast majority of AD patients develop the sporadic form of the 
disease around the age of 65 years. This neurodegenerative disease is, above all, a 
multifactorial disease with several identified environmental risk factors, the most prominent 
being age, and a growing list of genetic risk factors, which includes the important disease 
modifier APOE4 gene allel coding for a variant of apolipoprotein E. Familial forms of 
Alzheimer disease (FAD) concern less than 1 % of the patients and its clinical onset is 
usually earlierthan in the sporadic form (around 40-60 years). FAD is due to a dominant 
autosomal mutation in the amyloid precursor protein (APP) gene or one of the presenilin (PS) 
1 or 2 genes. These mutations will all favor the production of amyloid peptide (Aβ) by 
increasing β- or γ-secretase processing of APP (Cummings and Cole, 2002). In both forms of 
the disease, the preclinical stage of the disease was recently evidenced much earlier than 
initially thought with the first neuropathological signs detected several decades before AD 
diagnosis (Jack et al. 2010, Bateman et al. 2012). Individuals with mild cognitive impairment 
(MCI) are considered at high risk to develop the disease, especially those individuals 
showing memory deficits (aMCI - amnestic mild cognitive impairment). At this stage, the 
dramatic trajectory of an AD patient begins with difficulties i) in recalling recent events in their 
spatial and temporal context, ii) in remembering specific information about an object and/or 
its location and iii) in navigating efficiently through a newly encoutered environment. These 
deficits are considered to rely on episodic memory, recognition memory and spatial 
navigation memory, respectively. All three forms of memory are known to depend importantly 
on the medial temporal lobe (MTL; Lee et al. 2003; Kerchner et al. 2013; Nedelska et al. 
2012). Early appearance of these deficits is in accordance with the MTL being one the first 
targets of AD (Van Hoesen and Hyman, 1990; Braak and Braak, 1991; Stoub et al. 2006; but 
see also Aggleton et al. 2016; Douchamps and Mathis, 2017).  
Distribution and spreading of the two neuropathological hallmarks of the disease are 
quite different. Extracellular amyloid plaques mainly constituted of aggregated Aβ spread 
throughout the cortical mantle and some subcortical regions, whereas intracellular 
neurofibrillary tangles (NFTs) made of abnormally aggregated tau protein first appear in the 
entorhinal region before spreading to the hippocampus, neighbouring cortex and other brain 
areas (Delacourte et al. 1999). Brain atrophy is certainly one of the most prominent and 
wellknown feature of the disease at its latest stages. At the beginning of the disease, 
neurodegenerative processes launched by concomitant amyloid and tau pathology result in a 
progressive atrophy of MTL regions due to combined loss of cells and synapses.  
Imagery studies have repeatedly shown volumetric and functional alterations in the 
MTL of MCI and AD patients, with changes in entorhinal cortex and parahippocampal gyrus 
preceding those in hippocampus (Small et al. 2000; Eustache et al. 2001; Killiany et al. 
2002). Such alterations in the MTL were associated with impairments in recognition memory 
(Machulda et al. 2003; Wolk et al. 2011). Precocious dysfunctions have been related to AD 
pathology targeting the region corresponding to perirhinal cortex and lateral entorhinal cortex 
at an early stage (Delacourte et al. 1999; Kahn et al. 2014). These findings are of utmost 
importance considering OR memory as this region is thought to play a crucial role in 
processing information related to the identity of an object (i.e., according to its particular 
features) (Pihlajamäki et al. 2004; Mandzia et al. 2009; Sheldon and Levine, 2015; Fidalgo et 
al. 2016; Hirni et al. 2016; for review Didic et al. 2011). Within hippocampus, which seems to 
be affected slightly later than both the lateral entorhinal cortex and the perirhinal cortex, there 
is also a gradation in the vulnerability of hippocampal subregions with CA1 area and 
subiculum being first affected, and then other areas at later stages (Mueller et al. 2010; 
Kerchner et al. 2013). Progression of AD pathology to parahippocampal and hippocampal 
regions is most likely responsible for early deficits in OL memory (Smith and Milner, 1989; 
Bohbot et al 2002; Lee et al. 2003; Kessels et al. 2010; Hampstead et al. 2011; Das et al. 
2017), in addition to the well known involvement of the hippocampus in episodic memory and 
spatial navigation memory (Kerchner et al. 2013; Nedelska et al. 2012). In general, the 
hippocampus is viewed as a critical structure for context-rich recognition memory as opposed 
to a preferential involvement of cortical MTL in familiarity-based recognition. This view 
highlights the issue of a dual-process model of recognition memory, which dissociates 
familiarity related to a decontextualized feeling of knowing from conscious recollection of 
contextual-rich memories related to a specific episode (Yonelinas, 2002 ; Wolk et al. 2011 ; 
Schoemaker et al. 2014). Although deficits in both familiarity and recollection based 
recognition have been consistently reported in MCI and AD patients, some studies showed 
intact familiarity-based in one or both conditions (Algarabel et al. 2009; Ally et al. 2009; Wolk 
et al. 2008; but see Clark et al. 2012; Schoemaker et al. 2014). Discrepancies might be 
related to differences in cognitive status of selected populations (controls and patients), the 
nature of the material to be recognized and methodological limits (Schoemaker et al. 2014). 
In parallel to damage to the MTL, there is a marked shrinkage of basal forebrain cholinergic 
nuclei, which is thought to affect hippocampal and cortical cholinergic innervation at the MCI 
stage (Figure 1; Grothe et al. 2010; Schmitz et al. 2016). Several studies suggest that 
cholinergic degeneration in the basal forebrain cholinergic system contributes to recognition 
deficits in early AD (Goekoop et al. 2004; Grothe et al. 2010). Finally, after the onset of 
pathological events in the MTL, anatomical and functional alterations also develop at the 
level of the prefrontal cortex, which is known to have strong connections with both MTL and 
cholinergic basal forebrain (Figure 1; Delacourte et al. 1999; Hoppstädter et al. 2013). The 
prefrontal cortex has been involved in recognition memory especially when retrieval of 
object–related information is effortful whether it is due to long-term recall or the nature of the 
information (Owen et al. 1996; Mandzia et al. 2009). Early prefrontal dysfunction evidenced 
in MCI patients seems to participate in their deficits in both recollection and familiarity based 
recognition (Mandzia et al. 2009; Grothe et al. 2010; Hoppstädter et al. 2013).  
 
3. Object recognition paradigms used in humans 
Before moving to the neuroanatomy of OR memory in normal animals and AD models, 
it seems important to describe the tasks used for testing OR memory in humans and 
compare them to tasks used in animals. We will focus here on spontaneous recognition tasks 
based on unique or limited sampling trials for a given item, in other words excluding those 
based on extensive learning through multiple presentations of each item.  
Differing by means, experimental design and protocols, a wide variety of tasks are 
used to probe recognition memory in healthy humans and AD patients. Some tasks are 
based on the use of cards, pannels or paper sheets, while most others take advantage of 
computerized tests showing objects on a screen with changes in identity or position of the 
objects between sample and test trials. Objects can be displayed on a neutral 2-dimensional 
background or more recently within a 3-dimensional virtual environment (Figure 2). In many 
tasks, the material to be remembered is related to words presented through visual and/or 
auditory modalities (Schoemaker et al. 2014). However, some tasks use artificial shapes or 
real life objects although these are mainly shown in a 2-dimensional format (cards, boards 
and screens). Only very few studies tested humans in real world 3-dimensional set-ups 
reminiscent to those used in animals (e.g., Smith and Milner, 1989; Bohbot et al 2002). From 
a operational point of view, sampling trials in humans are sometimes grouped in long 
sequences before proceeding to recognition (test) trials, which may require more efforts due 
to delayed testing and eventual interference between samplings information (e.g., 160 words 
in Ally et al. 2009). Sample-test memory retention delays usually range from a few seconds 
to several minutes depending on the sampling schedule, but sometimes recall is performed 
on purpose at much longer intertrial intervals (ITIs) ranging from hours to days. Recognition 
performances can be evaluated either through yes-no recognition responses following 
presentation of individual items one by one (familiar or new), or alternatively through forced 
choice responses with two or more choice items (familiar item among new items) presented 
simultaneously. When studying recollection or familiarity based recognitions, the forced 
choice method is preferentially selected as it can be mediated by familiarity alone. However, 
successful responses can rely on both familiarity and recollection. To disentangle the two 
processes, refined procedures have been designed to quantify/assess the recollection nature 
of recalled information, for example through self-confidence rating of responses, 
complementary reports of specific contextual informations associated to the sampling 
episode or instruction to rely on contextual information present during sampling to give a 
correct answer (e.g., Schoemaker et al. 2014). The differentiation between recollection- and 
familiarity-based recognition is also under close scrutiny in animal studies, which actively 
participate to the ongoing debate concerning underlying neural substrates (Aggleton and 
Brown, 2006; Eichenbaum et al., 2007). However, animal studies add a level of complexity 
as it is not possible to ask animals to make introspective judgements or to rate their 
confidence in recognition judgements (but see Sauvage et al., 2008; Wixted and Squire, 
2008). As the issue of recollection and/or episodic memory is just beginning to be 
investigated in animal models of AD using recognition-based paradigms, which are still a 
matter of debate (Ennaceur, 2010), we will just evoke some of these studies below.  
 
4. Object exploration paradigm used in animal models of AD 
After a careful screening of more than 200 publications, it became evident that 
recognition memory in animal models of AD was essentially tested in the one-trial object 
exploration paradigm. This paradigm takes advantage of the spontaneous tendency of the 
animal to explore more a novel object or an object that moved to a new location within a 
familiar configuration of object, a natural behavioral response presumably driven by novelty 
detection (Berlyne, 1950). Ennaceur and colleagues designed the one-trial OR task and 
thereafter the one-trial OL task (Ennaceur and Delacour, 1988; Ennaceur et al., 1997).  Less 
than 10 years later, it has been adapted to mice (Dodart et al. 1997; Messier, 1997), and 
more recently to other species (Languille et al. 2015; Ardiles et al. 2012). Note that 
alternative multiple-trial tasks also based on object exploration paradigm have been 
designed in rodents and sometimes used in these AD models (Poucet et al. 1986; Roullet 
and Lassalle, 1990; Uekita et al. 2011).  
In a prototypical design of the one-trial paradigm (Figure 3), the animal is first allowed 
to explore two identical objects during a « sample » trial. Then, after a variable delay spent in 
its home cage or a holding cage, the animal is allowed to re-explore the same environment 
except that one of the two objects has been replaced by a novel object for the OR task or 
one of the familiar object was moved to a new location in the OL task (also called spatial 
recognition task). Each trial lasts between 3 and 15 min, the test trial being sometimes 
shorter as the animal tends to express its preference within the first few minutes of the test 
trial (Dix and Aggleton, 1999). Trial duration may also vary as a function of species, longer 
for mice than rats. Memory retention delays (or ITIs) were found to vary on a large scale, but 
most classically from a few minutes to 24 h (Ennaceur and Delacour, 1988). Spontaneous 
preference for novelty is maintained for several hours in both OR and OL tasks (Ennaceur 
and Delacour, 1988; Bour et al. 2004; Murai et al. 2007). In some case though, preference 
for the novel object can be extended to one or more days depending mainly on sampling 
efficiency, i.e., using highly different objects or extending the sample phase (Norman and 
Eacott, 2004; Albasser at al, 2009). The length of the retention delay is a critical issue that 
will determine whether the sample-test session taxes short-term or long term memories. 
Indeed, as highlighted below, recognition performance may depend on different sets of 
cerebral structure as a function of the length of ITIs. 
4.1 Neuroanatomical substrates of object recognition and object location tasks 
Over several decades, a long succession of invasive animal studies using various 
approaches to damage or alter hippocampal function have provided unexpected twists that 
fuelled an intense debate as to whether hippocampus plays a role in OR performance. 
According to the most recent advances, its role may vary as a function of both retention 
delay and experimental condition. Many studies have reported spared OR on a wide range of 
retention delays in hippocampal lesioned rats and mice (Mumby et al. 2002; Save et al. 
1992; Winters et al. 2004; Oliveira et al. 2010; Barker and Warburton, 2011; Sannino et al. 
2012). But in other studies, intact dentate gyrus (DG) or whole hippocampus was necessary 
when OR performance was evaluated after a 24-h ITI or even shorter delays after sampling 
(Clarck et al. 2000; Dees and Kesner, 2013). In some cases, the involvement of the 
hippocampus was shown to depend on lesion size, access to spatial cues (i.e., transparent 
walls), mutliple trials for arena habituation or sampling, or a large number of objects 
(Broadbent et al. 2004; Ainge et al. 2006; Oliveira et al. 2010; Dees and Kesner, 2013; 
Sannino et al. 2012). In other cases, modulating hippocampal activity by local infusion of 
pharmacological treatments could either improve or reduce long-term OR memory 
(Hammond et al. 2004; Oliveira et al. 2010; Melichercik et al. 2012; Cohen et al. 2013a).  
Therefore, one might propose that the contribution of hippocampus may depend on whether 
performance efficiency in a given task requires the establishment and recall of specific 
spatial representations or complex item binding, and/or the formation of an enduring memory 
trace. On the other hand, there is a general agreement on the critical involvement of 
hippocampus in OL memory on a wide range of ITIs, a consensual finding obtained using 
different experimental approaches (Save et al. 1992; Wan et al. 1999; Mumby et al. 2002; 
Lee et al. 2005; Assini et al. 2009; Manns and Eichenbaum, 2009; Oliveira et al. 2010; Burke 
et al. 2011a; Barker and Warburton, 2011; Place et al. 2012; Stupien et al. 2013). With 
similar consistency, perirhinal cortex, especially its most caudal part, was shown to play a 
key role in OR performance for ITIs of 5 min to 24 h (but not shorter) and with various 
experimental approaches (Ennaceur et al. 1996; Wan et al. 1999; Norman and Eacott, 2004; 
Winters et al. 2004; Barker et al. 2007; Albasser at al, 2009). It must be noted that the 
contribution of perirhinal cortex may also be influenced by object complexity given its 
involvement in the processing of perceptual properties of objects (Norman and Eacott, 2005; 
Bartko et al. 2007). When testing blind animals, it is important to know that posterior parietal 
cortex seemed more involved in OR than perirhinal cortex when only tactile exploration was 
possible (Winters and Ried, 2010). This issue needs to be further investigated, eventually 
from a translational point of view, because recognition tasks in humans are essentially based 
on vision whereas those in animals provide visual, haptic and proprioceptive perceptions of 
objects and their position in the environment. On the other hand, integrity of the perirhinal 
cortex does not seem to be necessary to perform OL tasks (Barker et al. 2007). Concerning 
the lateral and medial entorhinal cortex, electrophysiological and lesion data suggest that 
there is a graded involvement of both structures in object and spatial information, with 
preferential object related processing in the lateral region and contextual processing in the 
medial region (Deshmukh and Knierim, 2011; Hunsaker et al. 2013). Thus, lateral entorhinal 
cortex seems to integrate some spatial information to the purely nonspatial representations 
elaborated in the perirhinal cortex (Deshmukh et al. 2012; Tsao et al. 2013). Finally, the 
postrhinal cortex (parahippocampal cortex in primates) is considered as part of the 
spatial/contextual information processing pathway (Aminoff et al. 2013). Therefore, its 
specific role in object related recognition memory was not much investigated until recently in 
new variants of object exploration paradigms (see below), and also partly because post-
rhinal cortex and perirhinal cortex lesions were often combined in earlier studies (Wan et al. 
1999; Winters et al. 2004). Medial frontal cortex lesion did not seem to affect performance in 
OR or OL tasks (Poucet 1989; Ennaceur et al. 1997; Mitchell and Laiacona, 1998; Barker et 
al. 2007; Spanswick and Dyck, 2012). However, when normal functioning of this region is 
altered with pharmacological manipulations known to interfere with consolidation processes, 
then OR performance was shown to be affected after a 24-h, but not 3-h, ITI (Akirav and 
Maroun, 2006). Thus, medial prefrontal cortex appeared as an important hub in the neural 
network sustaining long-term consolidation of object-based recognition memory (Warburton 
and Brown, 2015). Finally, concerning the cholinergic system, there are a several studies 
suggesting that cholinergic basal forebrain inputs contribute to the respective role(s) of 
perirhinal cortex and hippocampus in OR and OL memories (Warbuton et al. 2003; Winters 
and Bussey, 2005; Hunsaker et al. 2007; Paban et al. 2010; Balderas et al. 2012; Melichercik 
et al. 2012). 
4.2 Variants of the object recognition paradigm 
As we are moving towards brain circuits encompassing medial prefrontal cortex and 
medial temporal lobe regions, it is necessary to evoke more recent variants of the object 
exploration paradigm, which are just beginning to be used in animal models of AD (see figure 
3). The first variant, often called the object-in-place (OiP) task, test the ability of the animal to 
detect the intrusion of a familiar object in the position previously occupied by a different 
familiar object (Dix and Aggleton, 1999). In other words, this task probes the specific 
association of object identity and place. Intact perirhinal cortex, medial prefrontal cortex and 
hippocampus as well as the dual interactions perirhinal cortex-hippocampus, perirhinal-
medial prefrontal cortex and lateral entorhinal-medial prefrontal cortex are necessary to 
perform the 4-object version of the OiP task (Figure 3; Barker et al. 2007; Barker and 
Warburton, 2015; DeVito and Eichenbaum, 2010; Chao et al. 2016; but see Goodrich-
Hunsaker et al. 2005 for hippocampus). The network underlying novelty detection 
performance in the OiP task may vary with the number of object and/or access to an 
allocentric (versus egocentric) spatial frame through arena-orienting cue(s) or changing start 
points. Indeed, “allocentric” 2-object OiP tasks seemed to rely mainly on lateral entorhinal 
cortex and hippocampus, but not perirhinal and postrhinal cortex (Eacott and Norman, 2004; 
Langston and Wood, 2010; Wilson et al. 2013b).  
The object-in-context (OiC) task was designed to test the ability of the animal to detect, 
which familiar object has never been presented in a specific, familiar context (Dix and 
Aggleton, 1999). In other words, the task focuses on the association between object identity 
and context. The integrity of postrhinal cortex and its interaction with the perirhinal cortex are 
mandatory in sustaining context-guided object recognition performance in OiC tasks 
(Norman and Eacott, 2005; Heimer-McGinn et al. 2017). It was proposed that a spatial layout 
of objects was first integrated in postrhinal cortex through its reciprocal connections with 
perirhinal cortex (Furtak et al. 2012). Downstream, an intact lateral entorhinal cortex and its 
interaction with medial prefrontal cortex are also necessary for OiC performance (Wilson et 
al. 2013a, 2013b; Chao et al. 2016). Additionally, lateral entorhinal cortex extends its 
involvement to the detection of mismatches in place to context and object-in-place to context 
combinations (tasks not shown), which suggests that this structure is necessary for further 
integration of object locations and/or to add OiP associations to the contextual layout (Wilson 
et al. 2013b). Note that one or the other role could be held by other(s) region(s), such as 
hippocampus (Hunsaker et al. 2013; but see Langston and Wood, 2010).  
As the recollection/familiarity debate is still a main issue in the domain of recognition 
memory research, two tasks were designed to evaluate some form of recollection of a past 
experience characterized i) by what happened, where and when (WWWhere task; Dere et al. 
2005) or ii) by what happened, where in which context (WWWhich; Eacott and Norman, 
2004). These tasks are therefore considered as probing an episodic-like memory in animals. 
As expected from the role of the hippocampus in context-rich memories, the ability to perform 
successfully WWWhen and WWWhich tasks on all three components requires an intact 
hippocampus, but not necessarily the integrity of other individual regions of medial temporal 
lobe such as perirhinal or postrhinal cortex (Eacott and Norman, 2004; Langston and Wood, 
2010; De Vito and Eichenbaum, 2010). Similarly to the object-in-place and object-in-context 
tasks, an intact interaction between lateral entorhinal cortex and medial prefrontal cortex is 
necessary to succeed in the WWWhen episodic-like memory task (Choa et al. 2016). When 
considering the memory for temporal order separately within these tasks or in a dedicated 
task, it is noteworthy that the hippocampus, the perirhinal cortex and the prefrontal cortex 
have all been reported to play a role in detecting object recency (Mitchell and Laiacona, 
1998; Barker et al. 2007; DeVito and Eichenbaum, 2010). Interestingly, the cholinergic septo-
hippocampal pathway was shown to contribute to OL-in-context recognition, but not 
WWWhich episodic-like memory, whereas extensive lesion of basal forebrain cholinergic 
nuclei altered more profoundly OR than OL performance (Easton et al. 2011; Matchynski et 
al. 2013).  
4.3 Concluding remarks on the relevance of the object recognition paradigm 
In summary, neuroanatomical substrates of recognition memory in animals are in 
general accordance with those found in human studies with OR being strongly dependent on 
perirhinal cortex and eventually on hippocampus and medial prefrontal cortex depending on 
task demand. On the other hand, OL memory was more dependent on the hippocampus. 
The hippocampus and/or extended circuits are recruited when more integrated and complex 
associations are under consideration. The existence of an acceptable coherence between 
human and animal studies was a prequisite for addressing the next issue on the use of these 
object-based recognition tasks in animal models of AD. 
 
5. Recognition memory and AD-like pathology in animal models  
Primary models of AD were mainly based on the cholinergic hypothesis of cognitive 
decline (Bartus et al. 1982). Thus, most models displayed reduced cholinergic system activity 
such as aged animals, pharmacological inhibition of cholinergic receptors (e.g., the 
wellknown scopolamine model) or lesion of cholinergic basal forebrain nuclei (Van Dam and 
De Deyn, 2006; Douchamps and Mathis, 2017). These models were instrumental in 
developing the few drugsapproved as AD directed therapies, such as cholinomimetics, that 
are still in use nowadays despite moderate efficacy. The cholinergic models have been 
completely surpassed by transgenic mouse models of AD. These models have been initially 
created by introducing FAD mutations into the mouse genome in order to induce amyloid 
pathology (Dodart et al. 2002b), whereas other mouse lines were created by introducing a 
mutation of familial frontotemporal dementia (FDT) to induce tau pathology (Götz, 2001). 
These single transgene mice and the following multiple transgenic mice have been extremely 
helpful in deciphering many pathological mechanisms related to AD. Although a large part of 
this section will be devoted to these transgenic models, we further expanded our interest to a 
few other rodent models and species that have been proposed as approaching sporadic AD 
models (e.g., Bons et al. 2006, Tarragon et al. 2013).  
5.1 The pioneer trio of AD transgenic mouse models 
Pionneer mouse models of AD overexpressing a human APP transgene bearing a FAD 
mutation were PDAPP mice, tg2576 mice and APP23 mice (Games et al. 1995; Hsiao et al. 
1996; Sturchler-Pierrat et al. 1997). PDAPP mice overexpress the APP717V→F FAD mutation 
under the platelet-derived growth factor β-subunit promoter, which leads to the development 
of amyloid plaques by 6-9 months in neocortical and hippocampal regions, as well as 
synaptic loss, astrogliosis and microgliosis (Games et al. 1995; Dodart et al. 2002b). This 
mouse line was first phenotyped in parallel by two groups who included the OR task in their 
battery of tasks (Dodart et al. 1999; Chen et al. 2000). In Chen et al (2000), PDAPP mice 
showed no deficit and a similar decay of OR performance than their wild type (WT) 
littermates over ITIs ranging from 10 s to 4 h. Conversely, in Dodart et al (1999), PDAPP 
mice were already deeply impaired from the age of 6 months onwards using a 3 h ITI. It was 
later proposed that differences in genetic background yielded such contrasting outcomes 
(Dodart et al. 2002b). OR deficits in PDAPP mice have been directly correlated to the 
progression of amyloid pathology in cingulate cortex and subregions of the hippocampus, but 
not to their nonprogressive hippocampal atrophy or their moderate perirhinal pathology 
(Dodart et al., 2000). A particularly pronounced DG pathology could have played a key role in 
OR deficits in PDAPP mice, as this region showed an early shrinkage, reduced adult 
neurogenesis and neural excitability, as well as preferential Aβ deposition in the termination 
zone of lateral entorhinal cortex inputs (Sánchez-Alavez et al. 2002; Redwine et al. 2003, 
Reilly et al. 2003; Donavan et al. 2006). A severe loss of cholinergic nerve terminals 
appeared between 2 and 4 months of age in neocortex, including cingulate cortex, and later 
on within the hippocampus, despite the fact that there is no loss of basal forebrain cholinergic 
neurons (German et al. 2003). This cholinergic defect might be involved in the neuronal 
hyperactivity recently revealed through in vivo two-photon imaging in the cortex of 5 month 
old PDAPP mice (Busche et al. 2015). In general, there is disappointing lack of overt 
neuronal loss in the PDAPP model as in most other APP transgenic mouse models, 
especially within the medial temporal lobe (Irizarry et al. 1997; reviewed in Cassel et al. 
2008). Nevertheless, PDAPP mice have been extensively used for testing passive 
immunisation directed against Aβ, which was shown to restore OR performances without 
altering brain Aβ burden and to normalise novelty-induced hippocampal acetylcholine release 
(Dodart et al. 2002a; Bales et al. 2006). Surprisingly, passive immunotherapy did not 
alleviate neuronal hyperactivation in the cortex of young PDAPP mice (Busche et al. 2015). 
In Tg2576 mice, overexpression of the APPK670N,M671L Swedish FAD mutation under the 
hamster prion protein promoter leads to marked amyloid deposition around 8-12 months of 
age with a pattern similar to that of PDAPP mice, including reactive gliosis, but more limited 
synaptic loss (Hsiao et al. 1996; Dodart et al. 2002b) Profound OR deficits have been shown 
in tg2576 mice from the age of 5-6 months onwards and with ITIs ranging from 50 min up to 
48 h (Mouri et al. 2007; Yuede et al. 2009; Ohta et al. 2012; Verret et al. 2013; Puri et al. 
2015). Only a few studies showed no OR deficits in tg2576 mice (5-14 months) when using 
repeated sampling trials or very short ITIs (2-3 min; Hale and Good, 2005; Ognibene et al. 
2005; Taglialatela et al. 2009). Conversely, tg2576 mice are deeply impaired in the OL task 
and the OL component of a WWWhere task from the age of 7 months onwards (Ognibene et 
al. 2005; Middei et al. 2006; Yassine et al. 2013; Lanté et al. 2015). These OL memory 
deficits are in accordance with wellknown anatomical and functional deteriorations reported 
in DG of 5-month old tg2576 mice (Jacobsen et al. 2006). Note that cholinergic markers in 
cortical regions and hippocampal acetylcholine release are reduced in 8-9 month old tg2576 
mice (Apelt et al. 2002; Watanabe et al. 2009). With this mouse line as in many others, 
critical advances have been made by uncovering very precocious signs of dysfunctions in 
regions relevant to early AD pathology and to recognition memory deficits. Spontaneous 
epileptiform activity and neuropathological signs of chronic seizures in the DG were detected 
at an early age of 1.5 months in Tg2576 mice (Bezzina et al. 2015). An in vivo imaging study 
showed hypermetabolism in several regions related to recognition memory, including 
perirhinal cortex, entorhinal cortex and hippocampus at an age as early as 3 months (Luo et 
al. 2012). At the same age, synaptic transmission and long-term synaptic depression were 
impaired in the perirhinal cortex while several studies detected abnormal neuronal 
hyperactivity in lateral entorhinal cortex more than in medial entorhinal cortex (Tamagnini et 
al. 2012; Marcantoni et al. 2014; Xu et al. 2015). These alterations in the perirhinal/lateral 
entorhinal cortex most probably lead to recognition deficits in the OR task and the OiP task 
(Hale and Good, 2005; Ohta et al. 2012; Puri et al. 2015). Finally, the Tg2576 mouse line has 
probably been one of the most commonly used AD model to test a wide variety of 
pharmacological (e.g., vaccine, dye, cholinomimetics, peptide inhibitor nanoparticles, 
calcineurin inhibitor) and behavioral (exercise, enriched housing) therapeutic approaches, in 
object-based recognition tasks (e.g., Mouri et al. 2007; Taglialatela et al. 2009; Yuede et al. 
2009; Ohta et al. 2012; Verret et al. 2013; Puri et al. 2015; Gregori et al. 2017). As found in 
PDAPP mice, passive immunotherapy had no effect on neuronal hyperactivation, it even 
worsened cortical activity in tg2576 mice (Busche et al. 2015). 
For the last of the pioneer mouse line trio, APP23 overexpressing the swedish double 
mutation APPK670N,M671L under the murine Thy-1.2 promoter (Sturchler-Pierrat et al. 1997), 
less studies have reported recognition performance. APP23 mice showed amyloid deposits 
beginning around the age of 6 months in cortical and hippocampal regions, as well as 
reactive gliosis (Sturchler-Pierrat et al. 1997). APP23 mice showed mild deficits in the OR 
task at 4 months of age and more profound deficits from 8 months onwards at ITIs of 1 h and 
24h (Heneka et al. 2006; Huang et al. 2006; Polito et al. 2014; Biella et al. 2016; Katsouri et 
al. 2016) and OL memory deficits at a 24-h ITI (Katsouri et al. 2016). Among neuroanatomic 
alterations that could have contributed to these deficits, there was moderate pyramidal cell 
loss in CA1, signs of degeneration in entorhinal cortex and aberrant hippocampal 
connections for entorhinal terminals (Calhoun et al. 1998, Phinney et al. 1999). Moderate 
loss of cholinergic innervation in cortical regions was found in 24-month old APP23 mice but 
no loss of basal forebrain cholinergic neurons (Boncristiano et al. 2002). Interestingly, APP23 
mice had to be crossed with the PSA5 mice (overexpressing a PS1G384A FAD mutation) in 
order to show early cortical and hippocampal hyperactivity, as found in other transgenic AD 
models (Busche et al. 2008; Busche et al. 2012). This neuronal dysfunction has very recently 
been rescued by treating APP23 x PSA5 mice with a β-secretase inhibitor, which reduces the 
production of Aβ and β-CTF intracellular domain of APP (Keskin et al. 2017). It is noteworthy 
that the PS1G384A mutation is also associated with hippocampal hyperactivation in the 
presymptomatic FAD patients (Quiroz et al. 2010).   
5.2 Multiple FAD mutations to increase AD-like pathology 
After these classical APP models, many mouse lines were created by cumulating one 
or more FAD APP mutations eventually in combination with PS1 or PS2 FAD mutation as 
those mutations alone lead to limited clinical and pathological signs (Duff et al. 1996; 
Borchelt et al. 1996). Combining several FAD mutations to increase phenotype aggressivity 
was mainly motivated by the practical advantage of providing amyloid plaque bearing mice at 
a much younger age than previous APP models. Here, we will concentrate on three of the 
most widely used multiple FAD mutation models: the TgCRND8 mice overexpressing 
Swedish APPK670N,M671L and Indiana APPV717F mutations (hamster prion promoter; Chishti et 
al. 2001), the  APPSWE/PS1dE9 mice transgenic for a chimeric Mo/HuAPP695SWE and 
PS1ΔE9 FAD mutations (Janowsky et al. 2004; Savonenko et al. 2005) and 5XFAD mice 
cumulating three APP FAD mutations and two PS1 mutations (Oakley et al. 2006).  
In TgCRND8 mice, the first amyloid deposits are found in the subiculum and the frontal 
cortex around the age of one month, whereas two months later amyloid pathology is 
widespread to many cortical regions and hippocampus (Chishti et al. 2001). In the OR task, 
profound deficits were found with ITIs ranging from 5 min to 3 h from the age of 3.5 months 
onwards, whereas reduced performance detected at the age of 2 months seemed to depend 
on testing conditions (Richter et al. 2008; Ambrée et al. 2009; Francis et al. 2012a,b; 
Romberg et al. 2012; Hamm et al. 2017). These deficits were rescued by physical exercise 
or pharmacological treatments interfering with cholinergic and glutamatergic systems such as 
rivastigmine and memantine or levodopa, all approved symptomatic treatments for AD or 
Parkinson’s disease, respectively (Richter et al. 2008; Ambrée et al. 2009; Francis et al. 
2012b; Romberg et al. 2012). Cholinomimetics might have improved OR performances 
through a beneficial effect on the cholinergic dysfunction in TgCRND8 mice (Belluci et al. 
2006). Two-month old TgCRND8 mice also showed deficits in the hippocampal-dependent 
OL task and allocentric 2-object version of the OiP task (Hamm et al. 2017). Interestingly, 
this study reported detailed analysis of network dysfunctions and differential sensitivity to 
inhibitors of β- or γ-secretase activities, which suggests that each deficit was induced by a 
different set of APP metabolites (Aβ versus β-CTF) in distinct hippocampal subregions. 
The original APPSWE/PS1dE9 mice on a C3B6 genetic background show amyloid 
deposition by 6 months of age (Janowsky et al. 2004). Their deficits in OR memory appear at 
the age of 7 months on a wide range of ITI from 1 h to 24 h (Frye and Walf, 2008; 
Jardanhazi-Kurutz et al. 2010; Mori et al. 2012; Zhang et al. 2012). OL memory is affected at 
the age of 6 months onwards when tested with 30 min to 4 h ITIs (Frye and Walf, 2008; 
Viana da Silva et al. 2016). However, sex and genetic background was shown to differentially 
affect the phenotype of this model. Indeed, APPSWE/PS1dE9 mice bred on a B6 background 
could show OR deficits at early ages of 4-6 months when tested with long ITIs of 4 and 24 h, 
and after the age of 7 months when ITIs were shorter (Mori et al. 2013; Matsuo et al. 2014; 
Woodling et al. 2016; Richetin et al. 2017). Similarly, OL performance was affected after an 
ITI of 1h in 10-12 months old APPSWE/PS1dE9 mice (Ma et al. 2013). At the age of 7-9 
months, females (but not males) bred on a B6 background showed OL memory deficits, 
which were associated to profoundly altered maturation of adult born DG neurons and robust 
astroglial activation (Richetin et al. 2017). Interestingly, young 3-4 months old 
APPSWE/PS1dE9 male mice bred on a B6 background showed prominent neuronal 
hyperexcitability and epileptiform activities within hippocampus, whereas 4-month old 
females showed increased electroencephalogram power and altered oscillatory activity in 
frontal and thalamic regions (Gurevicius et al. 2013; Minkeviciene et al. 2009). Moreover, 7-
month-old transgenic females on a B6 background showed a marked deterioration of 
cholinergic neurotransmission at the cortical level (Machovà et al. 2008). Thus, early 
hippocampal dysfunction combined to cholinergic abnormalities may participate to 
recognition memory deficits, impaired neurogenesis and abnormal cerebral activity in 
APPSWE/PS1dE9 female mice bred on a B6 background. Conversely, APPSWE/PS1dE9 mice 
bred on a mixed C3B6 background showed only modest cholinergic alterations at the age of 
10 months (Hartmann et al. 2010; Burke et al. 2013). Therefore, with this mouse model it 
seems important to carefully consider genetic background and sex before using this mouse 
model of AD. Although the background was not specified, it is interesting to note that 
APPSWE/PS1dE9 mice showed deficits in the WWWhere task at the age of 3 months and in 
the 4-object version of OiP task at the age of 5 months (Ramos-Rodriguez et al. 2013; 
Bonardi et al. 2016). As impaired DG neurogenesis is found in APPSWE/PS1dE9 mice bred on 
B6 and B6C3H backgrounds, it could account for some deficits in hippocampal-dependent 
task such as OL, OiP and WWWhere tasks (Taniuchi et al. 2007; Richetin et al. 2017). 
APPSWE/PS1dE9 mice have been useful in testing beneficial effects of a variety of 
pharmacological approaches such as progesterone, donezepil, tannic and ferulic acid, 
ibuprofen, inhibition of phosphodiesterase or A2A receptors (Frye and Walf, 2008; Mori et al. 
2012, 2013; Zhang et al. 2012; Viana da Silva et al. 2016; Woodling et al. 2016), and genetic 
manipulations (Ma et al. 2013; Richetin et al. 2015). It is interesting to note that the 
differential effect of progesterone treatment on OR performance, but not on the OL deficit of 
APPSWE/PS1dE9 mice, may be related to a selective improvement of cortical function (Frye 
and Walf, 2008).  
The 5XFAD model also show an accelerated amyloid pathology first characterized by 
cortical and subicular intraneuronal accumulation of Aβ at the age of 1.5 months, then 
amyloid deposition and reactive gliosis follows shortly at 2 months in cortical and 
hippocampal regions, whereas cortical neuronal loss and reduced synaptic markers were 
found at the age of 9 months (Oakley et al. 2006). This neuropathological pattern could have 
a deleterious impact on recognition memory processing. Indeed, 5xFAD mice showed OR 
memory deficits from the age of 4 months onwards at ITIs ranging from 30 min to 24 h (Woo 
et al. 2010; Tohda et al. 2011; Gianonni et al. 2013; Park et al. 2016; Ano et al. 2017). An OL 
memory deficit has recently been reported at the age of 6 months using a 24-h ITI (Park et 
al. 2016). Metabolic alterations were detected in frontal cortex, hippocampus, medial 
temporal lobe and thalamus of 5xFAD mice at the age of 8 months (Woo et al. 2010). The 
hippocampal and cortical epileptiform activities found in 5xFAD mice could be a driving force 
in amyloid pathology (Paesler et al. 2015). Indeed, chemogenetic attenuation of neural 
activity successfully reduced amyloid deposition, axonal dystrophy and synaptic loss in the 
cortex of both 5xFAD and APPSWE/PS1dE9 mice (Yuan and Grutzendler, 2016).  5xFAD mice 
were also used to evaluate beneficial effects of a 5HT4 receptor agonist, traditional asian 
medicine and iso-α-acid-containing diet (Tohda et al. 2011; Gianonni et al. 2013; Park et al. 
2016; Ano et al. 2017). 
5.3 Adding tau pathology to transgenic mouse models 
As models carrying FAD mutation showed only limited tau pathology, several models of 
tauopathy were created in parallel using transgenic expression of human tau gene (Mapt) 
carrying tau mutations associated to FTD, such as the FTDP-17 mutation (e.g., tauP301L). 
Note that there is no tau mutation inducing FAD. Most of the first tau mouse lines expressed 
extensive tau pathology and provided valuable data on NFTs formation, but their early 
neurological symptoms hampered behavioral testing (e.g., see JLNP3 mice, Lewis et al. 
2000). Although OR and OL tasks were less extensively used in tau models, recognition 
memory deficits were quite often found at the time tau pathology developed (Polydoro et al. 
2009; Sankaranarayanan et al. 2015; Kim etal, 2016). It did not take long for creating new 
mice expressing both APP and tau mutations in order to associate the two neuropathological 
hallmarks of AD. Among these multiple transgene models, the 3xTg-AD mice harboring 
APPK670N,M671L, PS1M146V and tauP301L mutations is one of the most widely used. It 
recapitulated salient AD-like amyloid and tau pathologies with early onsets at 4 and 6 
months, respectively (Oddo et al. 2003). The 3xTg-AD mice were deeply impaired in the OR 
task from the age of 6-7 months onwards with ITIs ranging from 15 min to 24 h, but not at a 
2-min ITI (Clinton et al. 2007; Blanchard et al. 2010; Martinez-Coria et al. 2010; Davis et al. 
2013a; Feld et al. 2014; Cantarella et al. 2015). At the ages of 9-12 months, 3xTg-AD mice 
failed in the OLT after a 24-h ITI (but not 2 min), in the allocentric 2-object version of OiP task 
with a 5-min ITI, but not in the OiC task with a 2-min ITI (Masciopinto et al. 2012; Davis et al. 
2013a). This mouse model showed its earliest deficits in a WWWhich task from 3 months of 
age onwards, but no deficits in a WWWhen task even at the age of 14 months (Davis et al. 
2013a,b). The pattern of deficit in these object-based recognition tasks is definitely coherent 
with early damage to the perirhinal cortex and at least some specific circuits including 
hippocampus, entorhinal cortex (allocentric OiP deficit) and medial prefrontal cortex (long-
term OR deficit). Indeed, this model is characterized by an early age-dependent 
intraneuronal accumulation of Aβ in the neocortex (3-4 months) and in the CA1 region of the 
hippocampus (6 months), which precedes the amyloid deposition first detected in the frontal 
cortex (6 months; Oddo et al. 2003). Reduction in CA1 synaptic plasticity appeared to be 
induced by this early amyloid pathology. The first signs of tau pathology were found at 6 
months of age within the CA1 region and it intensified and spread to cortical structures by the 
age of 12 months. This model also expressed early signs of glial activation in entorhinal 
cortex at the age of 3 months, increased excitability in CA1 and DG regions by 4-6 months 
and unstable CA1 spatial representations around 8-9 months (Janelsins et al. 2005; Davis et 
al. 2014; Mably et al. 2017). Interestingly, a pharmacological approach suggests that long-
term OR deficit in 3xTg-AD mice is due to a specific alteration in the intracellular ERK 
pathway within medial prefrontal cortex (Feld et al. 2014). As found in many mouse lines 
overexpressing a pathological form of human tau, it is important to emphasize that 3xTg-AD 
mice improved its AD-like neuropathological picture with almost one third loss of basal 
forebrain cholinergic neurons at the age of 4 months (Belarbi et al. 2011; Girão da Cruz et al. 
2012). This model was used to test the effects a wide range of therapeutic approaches, such 
as anti-inflammatory treatments, neurotrophic factors and memantine (Blanchard et al. 2010; 
Martinez-Coria et al. 2010; Cantarella et al. 2015).  
5.4 Transgenic rats expressing AD-like pathology 
There have been several attempts to create a transgenic rat model of AD, but only a 
few recent models seem to compete with transgenic mice for the moment, namely the 
McGill-R-Thy1-APP transgenic rat and the TgF344-AD rat (Leon et al. 2010; Cohen et al. 
2013b). The McGill-R-Thy1-APP rats express a single human APP transgene carrying both 
Swedish APPK670N,M671L and Indiana APPV717F mutations under the murine Thy-1.2 promoter 
(Leon et al. 2010). This rat showed intraneuronal Aβ accumulation within hippocampus and 
neocortex already a few days after birth. Moreover, extracellular amyloid deposits first 
appeared in subiculum and lateral entorhinal regions around the age of 6 months before 
spreading progressively throughout hippocampus and neocortical mantle. Given the recency 
of the model, studies evaluating recognition memory are fewer than for the previously 
described transgenic mice. Nevertheless, OL deficits were reported at an age of 9 months, 
whereas OR deficits seemed to appear later, around 13 months at the earliest (Galeano et 
al. 2014; Pimentel et al. 2015). TgF344-AD rats express both APPK670N,M671L and PS1ΔE9 
FAD mutations driven by the mouse prion promoter (Cohen et al. 2013b). In these rats, 
amyloidopathy and tauopathy was already detectable at 6 months of age and both prominent 
cerebral amyloid angiopathy and NFT-like structures were found at the age of 16 months. At 
this age, 23 to 45 % neuronal loss was reported in cingulate cortex and hippocampal regions. 
Moreover, 9 month-old TgF344-AD rats show reduced coherence of oscillatory activities 
within the hippocampal-medial prefrontal cortex network (Bazzigaluppi et al. 2017). 
Compatible with this finding and to the best of our knowledge, the only study investigating 
recognition memory in this model reported a profound deficit in 24 month old rats in the ORT 
(Cohen et al. 2013b). More extensive characterization is needed and will certainly follow to 
complete the pattern of recognition deficits in these two very interesting and promising AD rat 
models. 
5.5 Modeling AD pathology with stereotaxic injection of Aβ species 
The end of the present section will shift from these helpful transgenic animals modeling 
mainly FAD to other models closer to the sporadic form of AD. After a rapid overview of 
models ‘implanting’ AD-like pathology in specific brain regions, we will focus on two species 
that develop spontaneously an age-related pathology in many ways very close to AD. Quite 
popular in preclinical investigations, AD models can be induced in normal animals by 
injecting of Aβ species (Aβ1-40, Aβ1-42 or the Aβ25-35 fragment) in the cerebral ventricules or 
locally as in hippocampus or entorhinal cortex. All these treatments result evidently in 
cerebral accumulation of Aβ species, which can lead in some models to local Aβ deposits, 
ventricular enlargement, cholinergic abnormalities and eventually moderate neuronal loss 
(e.g., Maurice at al, 1996; Takeda et al. 2009; Chambon et al. 2011). OR deficits were found 
on a wide range of ITI (30 min to 24 h) in rats or mice tested 6 to 18 days after 
intracerebroventricular infusion of Aβ species (Kim et al. 2015; Zhang et al. 2016; Santos et 
al. 2017). Similar deficits were obtained in rats 10 and 30 days after local injection of Aβ1-42 
in hippocampus and entorhinal cortex, respectively (Sipos et al. 2007; He at al, 2013). 
Interestingly, perturbation of ERK signaling was again found in medial prefrontal cortex after 
intrahippocampal injection of Aβ1-42 and this pmolecular pathway dysfunction could be 
involved in long-term OR memory deficits associated to this model (Faucher et al. 2016). 
Finally, OL memory deficits were found in mice 15-16 days after intracerebroventricular 
administration of either Aβ1-40 or Aβ1-42 (Zhang et al. 2016; Lanznaster et al. 2016). Despite 
the variety of Aβ infusion models, it is noteworthy that they are usually associated with 
recognition deficits in OR and OL tasks and therefore this approach is widely used to test 
new therapies (He at al, 2013; Kim et al. 2015; Lanznaster et al. 2016; Zhang et al. 2016; 
Santos et al. 2017). 
5.6 Are ecological models closer to sporadic AD models? 
Mice and rats do not develop spontaneously AD pathology and their transgenic models 
do not recapitulate AD pathology, especially regarding to the prominent neuronal loss in the 
medial temporal lobe and basal forebrain cholinergic nuclei (Cassel et al., 2008). Among 
numerous proposed explanations, rat and mouse neurons may be less vulnerable than 
human neurons to neurotoxic effects of human Aβ or phosphorylated tau, species differences 
in tau as well as Aβ sequences makes them less prone to oligomerization and/or aggregation 
and evidently their lifespan is too short to allow the full development of degenerative events 
leading to neuronal loss in humans (Braidy et al. 2012). These limits combined with natural 
tendencies to generalize preclinical data to the human condition certainly contributed the 
recent questioning of the predictive value of rodent models of AD based mainly on the greatly 
disappointing outcomes of clinical trials testing several new potential therapeutic drugs 
(Jucker, 2010; Sasaguri et al. 2017). Therefore, animal models developing spontaneously 
Alzheimer-like pathology in old age offer an alternative and complementary approach to 
transgenic models and intracerebral Aβ injection.  
The mouse lemur (Microcebus murinus) is a highly interesting primate model of age-
associated neurodegeneration. One out of five elderly mouse lemur (around five years) 
develop an impressive brain atrophy affecting notably entorhinal, hippocampal and septal 
areas, a marked loss of basal forebrain cholinergic neurons, dense amyloid plaques in the 
temporal lobe and tau pathology in the neocortex (Bons et al. 2006, Picq et al. 2012). The 
reason for this intriguing development of a spontaneous AD-like neuropathology could rely 
on a long lifespan (8-12 year) and numerous genetic similarities with humans. The region 
coding for mouse lemur Aβ showed 100% homology with that of humans and their apoE 
gene sequence showed 92% similarity with the human APOE4 gene known as a major 
genetic risk for AD. Only in a subset of aged lemur mouse developed spatial navigation 
deficits related to hippocampal and entorhinal atrophy, and reduced behavioral flexibility 
predicted by septal atrophy (Picq et al. 2012). Similarly, reduced OR performance in a T-
maze appeared only at the long 24 h ITI in a subset of aged lemur (Languille et al. 2015). 
Whether OR deficits were related to specific alterations within subhippocampal structures 
such as perirhinal cortex still needs to be documented in this species.  
Over its 10-year lifespan, the degus (Octodon degu) was shown to develop 
spontaneous age-dependent AD-like neuropathology (Tarragon et al. 2013). Amyloid 
deposits were found in both cerebral cortex (frontal, parietal, temporal and entorhinal) and 
hippocampus of 3-year old degus (Inestrosa et al. 2005). Aβ oligomers accumulated 
progressively from the age of 6 months to 5 years, whereas levels of phosphorylated tau 
increased at the age of 3 years (Ardiles et al. 2012). Both Aβ oligomers and phosphorylated 
tau levels correlated with impairments in OR deficits displayed by 75% of the subjects. 
Memantine and other compounds efficient in mouse models of AD improved performances of 
middle-aged degus in OR and OL tasks (Tarragon et al. 2014; Rivera et al. 2016). Again, a 
relatively long lifespan and a high 97.5% homology between degus and human Aβ 
sequences might explain the natural development of AD-like neuropathology. It is noteworthy 
that some recent studies did not confirm the presence of AD-like pathology in degus (Steffen 
et al. 2016, Bourdenx et al. 2017). One of many possible explanations for such contrasting 
phenotypes could rely on the origin of experimental subjects. As spontaneous genetic drifts 
are commonly encountered in rodents, extensive breeding in captivity may have led to a loss 
of AD-like phenotype in some degus sublines. Nevertheless, further investigations are 
definitely needed to clarify this issue. 
 
6. CONCLUSIONS 
As announced at the beginning of this chapter, we mainly considered OR and OL tasks 
as animal models of AD were essentially tested in these tasks up to now. Among the reasons 
for this popularity, implementation appears easy and cheap, animal welfare is well preserved, 
and, last but not the least, the tasks tap two forms of recognition memory affected in AD. In 
addition, the vast majority of animal models of AD do show memory deficits in this paradigm. 
Consequently, it was also extensively used in preclinical studies to evaluate new therapies 
(Grayson et al. 2015). In general, we found that recognition deficits were in accordance with 
the pattern of development of AD-like pathology. Deficits in the hippocampal-dependent OL 
task appeared with timing compatible with early hippocampal alterations, such as intracellular 
accumulation of Aβ and/or neuronal hyperactivity. On the other hand, deficits in OR 
appeared less clearly related to the development of neuropathology in a specific anatomical 
region, most probably because the task depends on perirhinal cortex first, but also on 
hippocampus depending on testing conditions and on medial prefrontal cortex depending on 
the memory retention delay. Given the paucity of information on perirhinal cortex in studies 
investigating OR in AD models, one might suggest that the neuropathology of this region 
should be investigated at least as much as that of hippocampus in the future. Nevertheless, 
direct association between deficits in long-term OR memory and molecular pathway 
alterations in medial prefrontal cortex was elegantely demonstrated (Feld et al. 2014; 
Faucher et al. 2016). Further progresses are expected when AD models will be more widely 
tested in variants of the object exploration paradigm requiring specific associations between 
object, place, context and/or temporal order of presentation. Indeed most of these tasks 
appeared to depend on (slightly) different MTL and frontal networks. Thus, further defining 
those preferentially involved in each of these tasks will be extremely useful for a fine 
characterisation of the neuropathological events leading to specific cognitive deficits in AD 
models. Indeed, the previous section highlighted a few interesting examples of structure- or 
task-dependent effect of treatments possibly related to a preferential action on a particular 
set of structures or a region-specific pathology (Frye and Walf, 2008; Feld et al. 2014; Hamm 
et al. 2017). As the ultimate goal for testing recognition memory in models of AD is to 
develop efficient therapies against the disease, this type of information might be particularly 
useful in selecting a set of targets for the emerging multi-targeted therapeutic strategy.  
Given the urgent need for translational approaches, the concept behind the 
development of WWWhich and WWWhen paradigms provide an interesting extension of the 
recollection/familiarity debate from humans to animals, and possibly vice-versa (Easton et al. 
2012). Although there is still much to be done on these paradigms before reaching a 
consensual agreement on whether episodic-like memory can be tested in animals, 
researches on these tasks do follow the increasing effort to perform translational 
investigations on the most widely used behavioral paradigms in humans and in animals 
(Bobhot et al. 2002; Etchamendy et al. 2012; Possin et al. 2016). This approach is necessary 
to refine paradigm similarities between species and eventually clarify species differences that 
may limit translational interpretation and predictive value of animal models. In this regard, 
recent behavioral pattern separation tasks would merit a particular attention. These tasks 
resemble operationally to OR and OL tasks as they test the ability of the subject to detect 
whether an object or an object location is different from that previously encountered in 
sample trials. The particularity of these tasks is that the subject will have to express its 
choice during test trials with pictures (human) or sets of objects (animal) that can be 
identical, similar (lure) or very different (new foil) from those shown earlier (Gilbert et al. 
1998; Bakker et al. 2008; Burke et al. 2011b; Reagh and Yassa, 2014). Successful detection 
of the similar condition as being different is thought to rely conceptually on a pattern 
separation computation, which allows the resolution of interference among very similar 
memories. These tasks are thought to depend on the functional integrity of the MTL, and 
more specifically on the DG (Bakker et al. 2008; Reagh and Yassa, 2014). Our interest here 
is that these pattern separation tasks were shown to be extremely sensitive to very early 
stage of AD with clear deficits detected in aMCI patients (Stark et al. 2013). Moreover this 
deficit was associated with hyperactivity in the CA3-DG region and an antiepileptic treatment 
(leviracetam) was shown to reduce this hyperactivity and to improve pattern separation 
performance in aMCI patients (Bakker et al. 2015). This is clearly reminiscent of numerous 
studies conducted in animal models of AD showing neuronal hyperactivity in the MTL, 
particularly in the DG (Busche et al. 2008; Minkeviciene et al. 2009; Gurevicius et al. 2013; 
Davis et al. 2014; Bezzina et al. 2015; Paesler et al. 2015). One study even showed rescue 
of OR performance after normalisation of hippocampal activity with a leviracetam treatment 
in a mouse model of AD (Sanchez et al. 2012). Unfortunately, to the best of our knowledge, 
no study has been published with a pattern separation paradigm in models of AD despite the 
fact that our transgenic models are now considered as mainly useful to study early stages of 
AD-like pathology and better predictors of drug efficacy for asymptomatic stages of the 
disease (Zahs and Ashe, 2010). This is particularly true for this emerging new face of AD 
pathology, namely neuronal hyperactivity in the MTL (Busche et al. 2016). Many imagery 
studies showed indications of hyperactivity in the MTL of MCI and early AD patients, as well 
as presymptomatic FAD patients (Dickerson et al. 2005; Aslop et al. 2008; Quiroz et al. 2010; 
Bakker et al. 2015). These findings support the emerging view that hyperactivity is an early 
biomarker of the development of the disease. Thus, it is critical to further understand the 
causes of such an early dysfunction as well as the nature of protective/compensatory 
mechanisms that could regulate imbalance in excitability that lead to neuronal 
hyperexcitability within the MTL (Bott et al. 2017). Finally, a model of presymptomatic AD 
stages should ideally show cognitive deficits some time after the development of amyloid 
plaques and/or NFTs. Although this is not the case for the majority of the models reviewed 
above, this translationality requirement seems to be fulfilled by the second generation of AD 
models based uniquely on gene targeting technology (Sasaguri et al. 2017). 
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Figure 1: Simplified schematic representation of the medial temporal lobe network and 
its interactions with medial prefrontal cortex and cholinergic basal forebrain. Single-headed 
arrows are indicative of information flow within the medial temporal lobe, whereas double-
headed arrows are indicative of interactions between regions reported as important in object-
based recognition memory.  
 
Figure 2: Illustration of different experimental set ups used to test humans and animal 
models of AD. For humans, Ha represents the sketch of a room with three objects directly 
inspired from the real life set up used by Bohbot et al. 2002, Hb a set of board and cards 
often used in past studies, Hc the most widely used computer-based device and Hd a virtual 
reality tool that might be increasingly used in the future. For animals, Aa, Ab and Ac show the 
most common testing apparati such as square and circular arenas, and a T-maze, 
respectively. The mouse (Ad) and the rat (Ae) are the most widely used species in current 
models of AD, but other species may be considered for the future, such as the degu (Af) and 
the mouse lemur (Ag), which develop spontaneous age-dependent AD-like pathology. 
 
Figure 3: Schematic diagram of classical object recognition (OR) and object location 
(OL) tasks, as well as seven other variants of the object exploration paradigm used to test 
models of AD. The variants are the object-in-place (OiP) task, which exists in its 2-object and 
4-object versions, the object-in-context (OiC) task, the recency (or temporal order) task, and 
finally for the episodic-like paradigm with two versions of the what-where-when (WWWhen) 
task and also the what-where-which (WWWhich) task. 
  
 The practical box: hints, tips & tricks 
Testing apparatus. Animals are usually tested in square, rectangular or circular arena, 
seldom in L-, T- or Y-maze (Figure 2; Heyser and Ferris, 2013). The use of such maze can 
have the potential advantage to better drive the animal’s attention to the objects by reducing 
locomotor exploration and/or contextual surroundings (Winters et al. 2004). Dimension of 
sides or diameter are usually in a range of 30 to 60 cm, sometimes even more. Walls are 
usually opaque and between 20 and 50 cm high. A pattern card fixed on a wall or access to 
direct surroundings can be critical in orienting the arena for the object location (OL) task 
(Murai et al. 2007). Visual access to surroundings is an important aspect. First, it provides an 
additional spatial frame/context, which can expand the nature of the informations encoded by 
the animal and, consequently, determine the cerebral network critical for the task (Mumby et 
al. 2002; Takeda et al. 2009; Dees and Kesner, 2013). Second, low or transparent walls also 
increase the risk that the behavior of the animal can be disturbed by elements in the testing 
room (e.g., the experimenter). Therefore, trials are often recorded with a camera mounted 
over the arena, which offers the possibility to (blind) score the videos off line. Whenever 
specified, the room is sound-proof and background noise is rarely set over 50 dB. 
Illumination of the apparatus is usually in the low range, from 5 to 50 lx, as bright light is 
unconfortable to most species. Performing habituation sessions before the testing period is 
widespread and strongly recommended to reduce anxiety and stress related behaviors and 
to increase interest in the objects rather than spending time exploring the arena (Oliveira et 
al. 2010; Winters et al. 2004). As exploration behavior is tightly dependent on the well being 
of the animal, special care should be taken in ensuring minimal disturbance during the 
testing period, i.e., during testing and in the animal colony. 
There are a number of possible bias that should be taken into account when choosing 
and using objects in an object exploration paradigm. Importantly, objects to be discriminated 
should be very different (e.g., in terms of shape, material and color/brightness) to allow easy 
detection of novelty in basal conditions (e.g., fair amount of exploration, short retention 
delay). Throughout testing, care should be taken to keep the same orientation of the objects 
when their shape and/or color are assymetrical because object rotation can be detected 
(Roullet et al. 1998). Objects also exist in several identical copies so that each object 
presented during the test trial is a copy of the one(s) previously explored in the sample trial. 
This is mainly done to avoid any kind of bias due to unwanted marking, such as olfactory 
traces. Object are manipulated with gloves and cleaned between trials for the same reason. 
To neutralize other bias due to unexpected preference, the position of the novel object and 
the role as novel or familiar object among object type is often balanced across experimental 
groups. Finally, when using different types of objects within a trial, these should preferably be 
roughly the same size and known as similarily attractive to the animal based on preliminary 
tests (Heyser and Chemero, 2012).  
It is interesting to compare the tasks used in humans to those used in animals (Figure 
2). One common point is that there is no formal reward in the paradigms exposed in this 
chapter. Except for a few cases using objects in a room, tasks for humans are based on 
visual and eventually auditory (verbal) material. On the other hand, animals are essentially 
tested in a room with objects. This probably explains why the object recognition task is often 
defined as a visual recognition task, which is true for a large category of tasks used in 
humans, but rarely the case for those used in animals. Indeed, very few studies used objects 
of different color but same shape or two dimensional objects on a screen in animals (Wan et 
al. 1999; Joly et al. 2014; Delotterie et al., 2015; Heimer-McGinn et al. 2017). Touchscreen 
tasks will only be evoked here because, to our knowledge, only tasks with extensive training 
have been ponctually used in animal models of AD (Joly et al. 2014; Delotterie et al., 2015). 
As most tasks are not exclusively based on vision, it is important to take into account the 
specific sensory motor abilities of the animal model in regard to its capacity to discriminate 
object features, to display sufficient motility to ensure efficient exploration of the arena, and 
to experience of positional characteristics of the object. In this regard, it is extremely useful to 
know that some rodent strains have sensory problems related to their genetic background or 
the expression of their transgene. As found in AD patients, amyloid deposition may occur in 
the retina of some animal models of AD and thereby hamper their vision (Tsai et al. 2014, but 
see Joley et al. 2017; Chiu et al. 2012). Alternatively, vision is also known to be impaired in 
several albino rodents and in inbred mouse lines (e.g., Fisher-344, Wistar and Sprague-
Dawley rats; C3H/HeJ, FVB/NJ and SJL mice; Prusky et al. 2002; Wong and Brown, 2006). 
Many mouse models of AD are known to carry a recessive rd mutation leading to blindness, 
which is related to their mixed genetic background, such as Tg2576 and TgCRND8 mice on 
mixed B6SJL and C3B6 backgrounds, respectively. Surprinsingly, B6SJL mice homozygote 
for rd performed novel OR and OL tasks as well as sighted mice (Yassine et al. 2013). These 
findings clearly challenge the view that the OR task relies on visual discrimination in animals. 
The visual nature of most OR tasks in humans probably explains this wrong premise. 
Conversely, rodents have an extraordinary capacity to explore objects and environment with 
their vibrisses, which play a crucial role in the object exploration paradigm. Therefore, 
whisker loss (e.g., barbering behavior) or whiskers dysfunction due to the presence of a 
transgene may affect novel OR performance (Sarna et al. 2000; Flanigan et al. 2014). 
Concerning the OL task, given a variety of non visual information (e.g., haptic and 
kinesthetic, eventually olfactive and auditive) available during exploration of a new 
environment, blind rodents are still able to elaborate a spatial representation as they show 
fully functional place cells (Kimchi and Terkel, 2001; Save et al. 1998). This « cognitive 
map » would provide sufficient knowledge of the initial position of the objects within an arena 
to allow detection of an important object displacement during the test trial (Yassine et al. 
2003).  
Recognition performance is primarily evaluated by comparing exploration of the novel 
(location) object and exploration of the familiar (location) object. However, as total 
exploration of all objects may vary from one animal to the other, performance is often further 
espressed as an exploration ratio (or percentage) of time spent on the novel (location) object 
over total exploration of the objects, or a discrimination ratio (or percentage) of the difference 
between exploration times of the novel (location) object and the familiar (location) object over 
total exploration of the objects. Two important steps must be completed before moving on 
the interpretation of the data. First, total exploration of object during the sample trial should 
be comparable between groups as it could bias test performance. Second, the performance 
of each group should be compared to chance level, not only between groups. Indeed, except 
for particular study designs, it is better to verify that « healthy » groups are performing well 
over chance level while « pathological » groups are expected to show a deficit (complete or 
partial) unless they receive a treatment. Moreover, when performances are significantly lower 
than chance level this suggests that animals detected and avoided novelty associated to the 
object (due to neophobia). In other words, they did show object recognition memory. 
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